About
Dragan was CSO and co-founder of Covagen AG, a Swiss biotech company focusing on bispecific antibodies and antibody alternatives. Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson acquired Covagen in 2014. Since 2015 Dragan is an independent advisor in pharmaceutical biotechnology, start-up coach at ETH Zurich and Innosuisse (Swiss Innovation Agency), board member and entrepreneur. Dragan received his master’s degree in pharmaceutical sciences and Doctor of Sciences from ETH Zurich.
Sign up to see Dr. Dragan Grabulovski's full profile
Access investment thesis, focus areas, bio, and contact details for Dr. Dragan Grabulovski and 22,000+ other VC professionals.
Pureos Bioventures
Pfäffikon, CH